v2.4.0.8

Equity Method Investments and Joint Ventures (Tables) | 9 Months Ended | 12 Months Ended
--- | --- | ---
Sep. 30, 2013 | Dec. 31, 2012
Equity Method Investments And Joint Ventures [Abstract] |  |
Summarized Unaudited Financial Information | Summarized unaudited financial information for Ziopharm for the three and nine months ended September 30, 2013 and 2012 are as follows:
|  | Three months ended September 30, |  |  | Nine months ended September 30, |
|  | 2013 |  |  | 2012 |  |  | 2013 |  |  | 2012 |
Revenues |  | $ | 200 |  |  | $ | 200 |  |  | $ | 600 |  |  | $ | 600 |
Operating expenses |  |  | 9,315 |  |  |  | 21,927 |  |  |  | 51,592 |  |  |  | 63,926 |
Loss from operations |  |  | (9,115 | ) |  |  | (21,727 | ) |  |  | (50,992 | ) |  |  | (63,326 | )
Other |  |  | (7,598 | ) |  |  | 3,903 |  |  |  | 2,789 |  |  |  | (2,581 | )
Net loss |  | $ | (16,713 | ) |  | $ | (17,824 | ) |  | $ | (48,203 | ) |  | $ | (65,907 | )
| Summarized unaudited financial information for AquaBounty as of December 31, 2012 and for the period subsequent to the Company’s investment to December 31, 2012 is as follows:
|  | 2012 |
Current assets |  | $ | 514 |
Non-current assets |  |  | 1,962 |
Total assets |  |  | 2,476 |
Current liabilities |  |  | 706 |
Non-current liabilities |  |  | 2,741 |
Total liabilities |  |  | 3,447 |
Net liabilities |  | $ | (971 | )
|  | 2012 |
Revenues |  | $ | — |
Operating expenses |  |  | 578 |
Loss from operations |  |  | (578 | )
Other expense |  |  | (1 | )
Net loss |  | $ | (579 | )

X
- Details
Name: | us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6382943&loc=d3e33918-111571 + Details
Name: | us-gaap_EquityMethodInvestmentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration